Stock Detail
PERRIGO COMPANY
Sector: Drug Related Products
Latest Quote @ Wed May 5 06:38:12 (15 min delayed)
| $118.50 |
$118.89 |
$118.65 |
-0.38 |
-0.32% |
|
Last Day's Data
| $118.65 |
$119.31 |
$0.00 |
0.00% |
0.36 |
$119.03 |
| $118.59 |
$117.93 |
322,751.00 |
11.16B |
476,475.00 |
25.76 |
Pivot Table
| R2 |
R1 |
Pivot |
S1 |
S2 |
| 120.01 |
119.33 |
118.63 |
117.95 |
117.25 |
Stock Profile
Perrigo Company, through its wholly owned subsidiaries, engages in the manufacture and sale of consumer healthcare products, generic prescription drugs, active pharmaceutical ingredients (API), and consumer products primarily in the United States, Israel, Europe, and Mexico. The company operates in three segments; Consumer Healthcare, Rx Pharmaceuticals, and Active Pharmaceutical Ingredients. The Consumer Healthcare segment offers over-the-counter pharmaceutical and nutritional products in the United States, the United Kingdom, and Mexico. This segment offers analgesic, cough/cold/allergy/sinus, gastrointestinal, smoking cessation, first aid, vitamin, and nutritional supplement products. The Rx Pharmaceuticals segment engages in the development, manufacture, and sale of generic prescription drug products in the United States. This segment provides creams, ointments, lotions, gels, and solutions, as well as nasal sprays, foams, and transdermal devices. The Active Pharmaceutical Ingredients segment supports the development and manufacturing of API products in Israel and Germany, with sales to customers worldwide. The company also offers cosmetics, toiletries, detergents, manufactured and imported pharmaceutical products, and medical diagnostic products. The company's customers include national and regional retail drug, supermarket, wholesalers, and mass merchandise chains. Perrigo Company was founded in 1887 and is based in Allegan, Michigan.
